Publicacións nas que colabora con Juan Jesús Gómez-Reino Carnota (134)

2019

  1. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

    PLoS ONE, Vol. 14, Núm. 2

  2. Specific Association of HLA–DRB1*03 With Anti–Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 331-339

  3. Visfatin as a therapeutic target for rheumatoid arthritis

    Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 607-618

2018

  1. Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

  2. Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

    PLoS ONE, Vol. 13, Núm. 5

2017

  1. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient

    Journal of Orthopaedic Research, Vol. 35, Núm. 6, pp. 1299-1303

  2. Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients

    PLoS ONE, Vol. 12, Núm. 7

  3. Leptin in the interplay of inflammation, metabolism and immune system disorders

    Nature Reviews Rheumatology, Vol. 13, Núm. 2, pp. 100-109

2016

  1. Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies

    PLoS ONE, Vol. 11, Núm. 8

  2. Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study

    PLoS ONE, Vol. 11, Núm. 4

  3. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140

  4. Specific premature epigenetic aging of cartilage in osteoarthritis

    Aging, Vol. 8, Núm. 9, pp. 2222-2231

2015

  1. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  2. Basic Aspects of Adipokines in Bone Metabolism

    Clinical Reviews in Bone and Mineral Metabolism, Vol. 13, Núm. 1, pp. 11-19

  3. Choosing the right chondrocyte cell line: Focus on nitric oxide

    Journal of Orthopaedic Research, Vol. 33, Núm. 12, pp. 1784-1788

  4. Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice

    Journal of Bone and Mineral Metabolism, Vol. 33, Núm. 4, pp. 383-391

  5. FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors

    Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345

  6. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

  7. Identification of novel adipokines in the joint.Differential expression in healthy and osteoarthritis tissues

    PLoS ONE, Vol. 10, Núm. 4

  8. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: A brief history

    Drug Discovery Today